» Articles » PMID: 39220610

The Association Between Visceral Adipose Accumulation and Hyperuricemia Risk Among Chinese Elder Individuals: A Nationwide Prospective Cohort Study

Overview
Journal Prev Med Rep
Date 2024 Sep 2
PMID 39220610
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lipid accumulation product (LAP), visceral adiposity index (VAI) and Chinese visceral adiposity index (CVAI) are proposed indices of visceral adipose accumulation. This study aimed to explore their relationship and temporal changes with hyperuricemia (HUA) development in a Chinese population.

Methods: A total of 4268 participants aged ≥45 years from the baseline survey of the China Health and Retirement Longitudinal Study were followed up for 4 years (from 2011 to 2015). The relationships among VAI, LAP, CVAI and HUA were analyzed using logistic regression. The predictive abilities of the VAI, LAP and CVAI for HUA were compared using receiver operating characteristic curves. Nonlinear relationships between the indices and HUA were analyzed using restricted cubic spline regression.

Results: During the four-year follow-up, 415 (9.72 %) patients experienced incident HUA . Elevated baseline VAI (odds ratio (OR): 1.19 (95 % confidence interval (95 %CI: 1.10, 1.29)), LAP (OR: 1.21 (95 % CI: 1.09, 1.34)) and CVAI (OR: 1.19 (95 % CI: 1.02, 1.40)) were significantly correlated with increased HUA risk (all < 0.05). Compared to individuals with consistently low VAI,CVAIor LAP levels, those with elevated or consistently high levels of these indicators are more likely to have HUA. The area under curve (AUC) was slightly greater and more significant for the CVAI (AUC=0.641) than for the VAI (AUC=0.604) and LAP (AUC=0.628) ( < 0.05).

Conclusion: VAI, LAP and CVAI can predict HUA, with CVAI more efficient than VAI and LAP. Early management can lessen the burden of HUA in Chinese people aged 45 years or older with elevated CVAI levels.

Citing Articles

Association of Chinese visceral adiposity index with asymptomatic hyperuricemia incidence in type 2 diabetes: a cross-sectional study.

Wang Q, Liu T, Jia C, Wang P, Wang Y, He Q PeerJ. 2025; 13:e19045.

PMID: 40028208 PMC: 11871898. DOI: 10.7717/peerj.19045.

References
1.
Jiang J, Cui J, Yang X, Wang A, Mu Y, Dong L . Neck Circumference, a Novel Indicator for Hyperuricemia. Front Physiol. 2017; 8:965. PMC: 5712816. DOI: 10.3389/fphys.2017.00965. View

2.
Parsa A, Brown E, Weir M, Fink J, Shuldiner A, Mitchell B . Genotype-based changes in serum uric acid affect blood pressure. Kidney Int. 2011; 81(5):502-7. PMC: 3640827. DOI: 10.1038/ki.2011.414. View

3.
Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T . Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998; 47(8):929-33. DOI: 10.1016/s0026-0495(98)90346-8. View

4.
Chen Y, Zhang N, Sun G, Guo X, Yu S, Yang H . Metabolically healthy obesity also has risk for hyperuricemia among Chinese general population: A cross-sectional study. Obes Res Clin Pract. 2016; 10 Suppl 1:S84-S95. DOI: 10.1016/j.orcp.2016.03.008. View

5.
CASTELLI W . The triglyceride issue: a view from Framingham. Am Heart J. 1986; 112(2):432-7. DOI: 10.1016/0002-8703(86)90296-6. View